Stock listing
086 Stock Price, News, Filings & Events — Castle Biosciences, Inc.
Selected listing: 086 · TRADEGATE · EUR · DE
This page tracks Castle Biosciences, Inc.'s 086:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 086:TRADEGATE. 086:TRADEGATE is the stock-level entry point for investors researching Castle Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 086:TRADEGATE
- Asset type
- Stock
- Market cap
- $1.02B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- TRADEGATE
- Currency
- EUR
Castle Biosciences, Inc. 086:TRADEGATE stock context
This page tracks Castle Biosciences, Inc.'s 086:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 086:TRADEGATE. 086:TRADEGATE is the stock-level entry point for investors researching Castle Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Castle Biosciences, Inc.
Castle Biosciences Reports Second Quarter 2026 Results
July 30, 2026
Castle Biosciences to Present at the Canaccord Genuity 46th Annual Growth Conference
July 22, 2026
CoastalSouth Bancshares, Inc. Reports Earnings for Second Quarter 2026
July 20, 2026
Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test
July 14, 2026
Castle Biosciences : to Release Second Quarter 2026 Financial Results and Host Webcast on Thursday, July 30, 2026
July 9, 2026
Castle Biosciences, Inc. earnings calls
Castle Biosciences, Inc. (CSTL) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
Castle Biosciences, Inc. (CSTL) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Castle Biosciences, Inc. (CSTL) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Castle Biosciences, Inc. (CSTL) Q3 2025 Earnings Call
November 3, 2025 · Replay with transcript and chapters
Castle Biosciences, Inc. (CSTL) Q2 2025 Earnings Call
August 4, 2025 · Replay with transcript and chapters
Castle Biosciences, Inc. (CSTL) Q1 2025 Earnings Call
May 5, 2025 · Replay with transcript and chapters
Research Castle Biosciences, Inc.
Castle Biosciences, Inc. investor report
Review AI stock analysis and investor report context for 086:TRADEGATE.
Castle Biosciences, Inc. company profile
View the public company page for Castle Biosciences, Inc. on 6ix.
Castle Biosciences, Inc. news
Read company news and market updates connected to Castle Biosciences, Inc..
Castle Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Castle Biosciences, Inc..
Alternate listings
CSTL:NASDAQ
US · USD
Alternate listing for Castle Biosciences, Inc.; the primary context on this page is 086:TRADEGATE.
086:FWB
DE · EUR
Alternate listing for Castle Biosciences, Inc.; the primary context on this page is 086:TRADEGATE.
CSTL:BOATS
US · USD
Alternate listing for Castle Biosciences, Inc.; the primary context on this page is 086:TRADEGATE.